phloroglucinol has been researched along with Carcinoma, Lewis Lung in 1 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kwon, YH | 1 |
Jung, SY | 1 |
Kim, JW | 1 |
Lee, SH | 1 |
Lee, JH | 1 |
Lee, BY | 1 |
Kwon, SM | 1 |
1 other study available for phloroglucinol and Carcinoma, Lewis Lung
Article | Year |
---|---|
Phloroglucinol inhibits the bioactivities of endothelial progenitor cells and suppresses tumor angiogenesis in LLC-tumor-bearing mice.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Lewis Lung; Cell Movem | 2012 |